Sign in to see your portfolio and net worth.
Your portfolio is private to your account. We store only a scrambled version of your password.
| Asset | Shares | Avg cost | Price | Value | Return | Today |
|---|
Thermo Fisher Scientific's gross profit was $11.9 billion for the fiscal year ended December 2017, up 18.7% from $10.1 billion a year earlier. In fiscal 2012 it was $6.4 billion. In the most recent quarter (ended March 2018) gross profit was $3.5 billion, +33.8% from the same quarter a year earlier.
| Fiscal year | Gross profit | Change |
|---|---|---|
| 2017 | $11.9 billion | +18.7% |
| 2016 | $10.1 billion | +7.2% |
| 2015 | $9.4 billion | +4.8% |
| 2014 | $9.0 billion | +32.1% |
| 2013 | $6.8 billion | +5.8% |
| 2012 | $6.4 billion |
More for TMO: Revenue · Operating income · EBITDA · Net income · Earnings per share (EPS) · Shares outstanding · Free cash flow · P/E ratio · All-time high
Source: SEC filings (10-K and 10-Q). Quarterly and trailing 12-month charts are in the interactive chart above.
AAPL · MSFT · NVDA · GOOGL · AMZN · META · TSLA · BRK-B · AVGO · LLY · JPM · V · WMT · XOM · UNH · MA · ORCL · COST · HD · PG · JNJ · NFLX · BAC · ABBV